Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 15;93(5):422-430.
doi: 10.1097/QAI.0000000000003215.

Association of Pregnancy and HIV Status With Molecular-Bacterial Vaginosis in Indian Women

Affiliations

Association of Pregnancy and HIV Status With Molecular-Bacterial Vaginosis in Indian Women

Susan Tuddenham et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Bacterial vaginosis (BV) is a highly prevalent disorder of the cervicovaginal microbiota. Molecular-BV may put women at increased risk for adverse reproductive and obstetric outcomes. We investigated the association of HIV and pregnancy on the vaginal microbiota and associations with molecular-BV in women of reproductive age from Pune, India.

Setting: We studied vaginal samples from N = 170 women, including N = 44 nonpregnant HIV seronegative, N = 56 pregnant seronegative, N = 47 nonpregnant women with HIV (WWH), and N = 23 pregnant WWH, and collected data on clinical, behavioral, and demographic factors.

Methods: We used 16S rRNA gene amplicon sequencing to characterize the composition of the vaginal microbiota. We classified the vaginal microbiota of these women into community state types based on bacterial composition and relative abundance and further categorized them into molecular-BV versus Lactobacillus -dominated states. To determine associations between pregnancy and HIV status with outcome of molecular-BV, logistic regression models were used.

Results: There was a high prevalence of molecular-BV (30%) in this cohort. We found that pregnancy was associated with decreased odds of molecular-BV (adjusted OR = 0.35, 95% CI: 0.14 to 0.87), while HIV was associated with increased odds of molecular-BV (adjusted OR = 2.76, 95% CI: 1.33 to 5.73), even when controlling for multiple relevant factors such as age, number of sexual partners, condom use, and douching.

Conclusion: Larger and longitudinal studies are needed to further characterize molecular-BV and the vaginal microbiota in pregnant women and WWH and relate these factors to infectious, reproductive, and obstetric outcomes. In the long term, these studies may lead to novel microbiota-based therapeutics to improve women's reproductive and obstetric health.

PubMed Disclaimer

Conflict of interest statement

JR is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. ST has been a consultant for Biofire Diagnostics, Roche Molecular Diagnostics and LUCA Biologics, receives royalties from UPTODATE and has received speaker honoraria from Roche Molecular Diagnostics and Medscape/WebMD. For the remaining authors none were declared.

Research reported in this publication was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number R00HD089753 to RS, R01HD081929 to AG, as well as NIAID (K23AI129854 to JSM). Additional support for this work was the NIH-funded Johns Hopkins Baltimore-Washington-India Clinical Trials Unit for NIAID Networks (UM1AI069465 to AG). JR, MSH and JBH were supported by the National Institute of Nursing Research, of the National Institute of Health under award number R01NR015495. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. The authors also acknowledge in-kind support from Persistent Systems and SpeeDx.

Figures

Figure 1
Figure 1. Heatmap of the Vaginal Microbiota
Heatmap of relative abundance of the 30 most abundant phylotypes in the vaginal microbiota of N=170 women enrolled in the study. The vaginal microbiota was characterized by high-throughput sequencing of the V3–V4 variable regions of 16S rRNA genes. The two sidebars indicate community state types (CSTs) and HIV/Pregnancy groups. CST I=L. crispatus dominated, CST II=L. gasseri dominated, CST III=L. iners dominated, CST IV-A (high to moderate relative abundance of Ca. Lachnocurva vaginae and G. vaginalis), CST IV-B (high to moderate relative abundance of G. vaginalis and A. vaginae), and CST IV-C (low relative abundances of G. vaginalis, Ca. Lachnocurva vaginae, and Lactobacillus spp. and included a diverse array of other bacterial groups such as Prevotella spp., Streptococcus spp., Enterococcus spp., Bifidobacterium spp., and Staphylococcus spp.). Collectively CST IV=molecular-BV. Abbreviations:- SN: HIV-seronegative women; WWH: woman with HIV.

References

    1. Kroon SJ, Ravel J, Huston WM. Cervicovaginal microbiota, women’s health, and reproductive outcomes. Fertil Steril. Aug 2018;110(3):327–336. doi:10.1016/j.fertnstert.2018.06.036 - DOI - PubMed
    1. France M, Alizadeh M, Brown S, Ma B, Ravel J. Towards a deeper understanding of the vaginal microbiota. Nat Microbiol. Mar 2022;7(3):367–378. doi:10.1038/s41564-022-01083-2 - DOI - PMC - PubMed
    1. Tuddenham S, Ravel J, Marrazzo JM. Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections. J Infect Dis. Jun 16 2021;223(12 Suppl 2):S222–S235. doi:10.1093/infdis/jiaa762 - DOI - PMC - PubMed
    1. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. Jan 1983;74(1):14–22. doi:10.1016/0002-9343(83)91112-9 - DOI - PubMed
    1. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. Feb 1991;29(2):297–301. - PMC - PubMed

Publication types

Substances